This inventor holds 3 USPTO granted patents and 2 published patent applications. Top assignees: Boehringer Ingelheim International Gmbh, Ose Immmnotherapeatics Sa. Active years: 2023-2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:

Years Active: 2023-2026
Title: Yining Huang: Innovator in Vascular Eye and Retinal Diseases
Introduction
Yining Huang is a notable inventor based in Belmont, MA (US). He has made significant contributions to the field of medical treatments, particularly in addressing vascular eye and retinal diseases. With a total of 3 patents to his name, Huang's work is recognized for its innovative approach and potential impact on patient care.
Latest Patents
Huang's latest patents include groundbreaking methods such as the "Method of Treating Vascular Eye and Retinal Diseases by Administration of Anti-Neuropilin 1A Antibodies" and "Anti-SIRP-Alpha Antibodies." These patents reflect his commitment to advancing medical science and improving therapeutic options for patients suffering from complex eye conditions.
Career Highlights
Throughout his career, Yining Huang has worked with prominent companies in the pharmaceutical and biotechnology sectors. Notably, he has been associated with Boehringer Ingelheim International GmbH and Ose Immunotherapeutics. His experience in these organizations has allowed him to develop and refine his innovative ideas, contributing to the advancement of medical treatments.
Collaborations
Huang has collaborated with several professionals in his field, including Pankaj Gupta and Priyanka Gupta. These collaborations have fostered a dynamic exchange of ideas and expertise, further enhancing the quality and impact of his work.
Conclusion
Yining Huang stands out as an influential inventor in the realm of medical innovations, particularly in the treatment of vascular eye and retinal diseases. His patents and collaborations highlight his dedication to improving healthcare outcomes through innovative solutions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile